Krynica Vitamin S.A. (WSE:KVT)
9.74
+0.04 (0.41%)
Jun 27, 2025, 4:28 PM CET
Krynica Vitamin Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 385.47 | 387.89 | 357.12 | 377.16 | 395.31 | 445.94 | Upgrade
|
Other Revenue | - | - | - | - | 0 | - | Upgrade
|
385.47 | 387.89 | 357.12 | 377.16 | 395.31 | 445.94 | Upgrade
| |
Revenue Growth (YoY) | 3.02% | 8.62% | -5.31% | -4.59% | -11.35% | 50.26% | Upgrade
|
Cost of Revenue | 320.23 | 323.54 | 304.63 | 310.91 | 336.78 | 326.33 | Upgrade
|
Gross Profit | 65.24 | 64.36 | 52.49 | 66.25 | 58.53 | 119.61 | Upgrade
|
Selling, General & Admin | 47.54 | 48.5 | 44.66 | 44.87 | 40.28 | 36.71 | Upgrade
|
Other Operating Expenses | -2.98 | -3.34 | -0.77 | 0.51 | -5.14 | 7.29 | Upgrade
|
Operating Expenses | 44.56 | 45.17 | 43.88 | 45.38 | 35.15 | 44 | Upgrade
|
Operating Income | 20.68 | 19.19 | 8.61 | 20.88 | 23.39 | 75.61 | Upgrade
|
Interest Expense | -3.14 | -3.62 | -4.32 | -3.56 | -0.91 | -0.97 | Upgrade
|
Interest & Investment Income | 0 | 0 | 0 | 0 | 0.08 | 0 | Upgrade
|
Other Non Operating Income (Expenses) | 0.98 | 0.62 | 0.62 | 1.02 | 1.3 | -1.84 | Upgrade
|
EBT Excluding Unusual Items | 18.52 | 16.19 | 4.91 | 18.34 | 23.86 | 72.81 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.01 | 0.04 | 0.09 | -0.05 | -0.06 | 0.04 | Upgrade
|
Asset Writedown | -2.42 | -2.42 | 0.37 | -4.14 | -2.8 | -1.3 | Upgrade
|
Other Unusual Items | - | - | -12.1 | - | - | - | Upgrade
|
Pretax Income | 16.11 | 13.81 | -6.74 | 14.15 | 21 | 71.55 | Upgrade
|
Income Tax Expense | 1.82 | 1.58 | -0.05 | 1.07 | 5.42 | 14.62 | Upgrade
|
Net Income | 14.29 | 12.23 | -6.68 | 13.08 | 15.58 | 56.93 | Upgrade
|
Net Income to Common | 14.29 | 12.23 | -6.68 | 13.08 | 15.58 | 56.93 | Upgrade
|
Net Income Growth | - | - | - | -16.05% | -72.63% | 706.06% | Upgrade
|
Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | 12 | Upgrade
|
Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | 12 | Upgrade
|
Shares Change (YoY) | -0.01% | - | - | - | - | - | Upgrade
|
EPS (Basic) | 1.17 | 1.00 | -0.55 | 1.07 | 1.27 | 4.65 | Upgrade
|
EPS (Diluted) | 1.17 | 1.00 | -0.55 | 1.07 | 1.27 | 4.65 | Upgrade
|
EPS Growth | - | - | - | -16.05% | -72.63% | 706.05% | Upgrade
|
Free Cash Flow | 25.45 | 20.19 | 13.68 | -1.75 | -7.41 | 58.06 | Upgrade
|
Free Cash Flow Per Share | 2.08 | 1.65 | 1.12 | -0.14 | -0.60 | 4.74 | Upgrade
|
Dividend Per Share | - | - | - | 0.200 | - | - | Upgrade
|
Gross Margin | 16.92% | 16.59% | 14.70% | 17.57% | 14.81% | 26.82% | Upgrade
|
Operating Margin | 5.36% | 4.95% | 2.41% | 5.54% | 5.92% | 16.96% | Upgrade
|
Profit Margin | 3.71% | 3.15% | -1.87% | 3.47% | 3.94% | 12.77% | Upgrade
|
Free Cash Flow Margin | 6.60% | 5.21% | 3.83% | -0.46% | -1.87% | 13.02% | Upgrade
|
EBITDA | 34.55 | 32.81 | 22.79 | 33.53 | 35.94 | 87.37 | Upgrade
|
EBITDA Margin | 8.96% | 8.46% | 6.38% | 8.89% | 9.09% | 19.59% | Upgrade
|
D&A For EBITDA | 13.87 | 13.62 | 14.18 | 12.66 | 12.55 | 11.76 | Upgrade
|
EBIT | 20.68 | 19.19 | 8.61 | 20.88 | 23.39 | 75.61 | Upgrade
|
EBIT Margin | 5.36% | 4.95% | 2.41% | 5.54% | 5.92% | 16.96% | Upgrade
|
Effective Tax Rate | 11.29% | 11.44% | - | 7.55% | 25.81% | 20.43% | Upgrade
|
Revenue as Reported | 385.47 | 387.89 | 357.12 | 377.16 | 395.31 | 445.94 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.